How big is the Europe Genetic Testing Market?

The Europe Genetic Testing Market size is expected to reach USD 6.17 billion in 2024 and grow at a CAGR of 10.55% to reach USD 10.19 billion by 2029. Read More

What is the current Europe Genetic Testing Market size?

In 2024, the Europe Genetic Testing Market size is expected to reach USD 6.17 billion. Read More

Who are the key players in Europe Genetic Testing Market?

Abbott Laboratories, Illumina Inc., 23andMe Inc., Qiagen and F. Hoffmann-La Roche Ltd are the major companies operating in the Europe Genetic Testing Market. Read More

What years does this Europe Genetic Testing Market cover, and what was the market size in 2023?

In 2023, the Europe Genetic Testing Market size was estimated at USD 5.58 billion. The report covers the Europe Genetic Testing Market historical market size for years: 2021, 2022 and 2023. The report also forecasts the Europe Genetic Testing Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Europe Genetic Testing Market - Companies, Size & Share

Europe Genetic Testing Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Report Covers Genetic Testing in Europe and the Market is Segmented by Type (Carrier Testing, Diagnostic Testing, Newborn Screening, Predictive and Presymptomatic Testing, Prenatal Testing, and Other Types), By Disease (Alzheimer's Disease, Cancer, Cystic Fibrosis, Sickle Cell Anemia, Duchenne Muscular Dystrophy, Thalassemia, Huntington's Disease, Other Diseases), By Technology (Cytogenetic Testing, Biochemical Testing, and Molecular Testing), and Geography (Germany, United Kingdom, France, Italy, Spain, and Rest of Europe). The market sizes and forecasts are provided in terms of value (USD million) for all the above segments.

Europe Genetic Testing Industry Overview

The European Genetic Testing Market is moderately competitive and consists of several major players. Factors such as technological advancements and product innovations, mid-size to smaller companies are increasing their market presence by introducing new products with fewer prices are expected to drive the market growth. The major players operating in this market include Illumina Inc., Abbott Laboratories, Qiagen, Eurofins Scientific, F. Hoffmann-La Roche Ltd, and 23andMe Inc., among others.